NO174509B - Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater Download PDF

Info

Publication number
NO174509B
NO174509B NO894734A NO894734A NO174509B NO 174509 B NO174509 B NO 174509B NO 894734 A NO894734 A NO 894734A NO 894734 A NO894734 A NO 894734A NO 174509 B NO174509 B NO 174509B
Authority
NO
Norway
Prior art keywords
formula
parts
alkyl
residue
compounds
Prior art date
Application number
NO894734A
Other languages
English (en)
Norwegian (no)
Other versions
NO894734L (no
NO174509C (pt
NO894734D0 (no
Inventor
Eddy Jean Edgard Freyne
Marc Gaston Venet
Alfons Herman Margaretha
Gerard Charles Sanz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888827820A external-priority patent/GB8827820D0/en
Priority claimed from GB888827822A external-priority patent/GB8827822D0/en
Priority claimed from GB888827821A external-priority patent/GB8827821D0/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO894734D0 publication Critical patent/NO894734D0/no
Publication of NO894734L publication Critical patent/NO894734L/no
Publication of NO174509B publication Critical patent/NO174509B/no
Publication of NO174509C publication Critical patent/NO174509C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Quinoline Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO894734A 1988-11-29 1989-11-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater NO174509B (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888827820A GB8827820D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives
GB888827822A GB8827822D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives
GB888827821A GB8827821D0 (en) 1988-11-29 1988-11-29 (1h-azol-1-ylmethyl)substituted quinoline derivatives

Publications (4)

Publication Number Publication Date
NO894734D0 NO894734D0 (no) 1989-11-28
NO894734L NO894734L (no) 1990-05-30
NO174509B true NO174509B (no) 1994-02-07
NO174509C NO174509C (pt) 1994-05-18

Family

ID=27264207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894734A NO174509B (no) 1988-11-29 1989-11-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater

Country Status (22)

Country Link
EP (1) EP0371564B1 (pt)
JP (1) JP2916181B2 (pt)
CN (3) CN1033752C (pt)
AT (1) ATE124941T1 (pt)
AU (1) AU620946B2 (pt)
CA (1) CA2002864C (pt)
CY (1) CY1920A (pt)
DE (1) DE68923430T2 (pt)
DK (1) DK172748B1 (pt)
ES (1) ES2088889T3 (pt)
FI (1) FI101964B1 (pt)
GR (1) GR3017351T3 (pt)
HK (1) HK118196A (pt)
HU (2) HU205106B (pt)
IE (1) IE67803B1 (pt)
IL (1) IL92486A (pt)
MY (1) MY105871A (pt)
NO (1) NO174509B (pt)
NZ (1) NZ231441A (pt)
PT (1) PT92448B (pt)
RU (1) RU1780536C (pt)
ZW (1) ZW15889A1 (pt)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
US5589484A (en) * 1992-10-27 1996-12-31 Janssen Pharmaceutica N.V. 4-quinolinyl derivatives
NO940245D0 (no) * 1993-01-28 1994-01-24 Takeda Chemical Industries Ltd Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
DE69425804T2 (de) * 1993-06-17 2001-02-08 Otsuka Pharmaceutical Factory, Inc. Phosphonsäurediesterderivate
TW316902B (pt) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
DE69620445T2 (de) * 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
RU2205831C2 (ru) 1997-04-25 2003-06-10 Янссен Фармацевтика Н.В. Хиназолиноны, ингибирующие фарнезилтрансферазу
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
AU2160899A (en) 1997-12-11 1999-06-28 Janssen Pharmaceutica N.V. Retinoic acid mimetic anilides
DE69923849T2 (de) * 1998-08-27 2006-01-12 Pfizer Products Inc., Groton Quinolin-2-on-derivate verwendbar als antikrebsmittel
DK1140935T3 (da) * 1998-12-23 2003-09-01 Janssen Pharmaceutica Nv 1,2-anellerede quinolinderivater
EP1295878B1 (en) * 2000-06-30 2004-09-15 Banyu Pharmaceutical Co., Ltd. Pyrazinone derivatives
US7067531B2 (en) 2000-09-25 2006-06-27 Angibaud Patrick Rene Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
JP4974437B2 (ja) 2000-09-25 2012-07-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する６−［（置換フェニル）メチル］−キノリンおよびキナゾリン誘導体
DE60118225T2 (de) 2000-09-25 2007-05-03 Janssen Pharmaceutica N.V. Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
WO2002024686A2 (en) 2000-09-25 2002-03-28 Janssen Pharmaceutica N.V. Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
AU2002214056A1 (en) * 2000-11-21 2002-06-03 Janssen Pharmaceutica N.V. Farnesyl transferase inhibiting benzoheterocyclic derivatives
JP4351445B2 (ja) 2000-12-27 2009-10-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する４−置換−キノリンおよびキナゾリン誘導体
KR100417705B1 (ko) * 2001-07-24 2004-02-11 한국화학연구원 4-아졸일-2-퀴놀리논 유도체 및 이를 포함하는 살균제조성물
DE60307616T2 (de) 2002-04-15 2007-10-04 Janssen Pharmaceutica N.V. Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen
FR2860235A1 (fr) * 2003-09-29 2005-04-01 Yang Ji Chemical Company Ltd Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
EA011211B1 (ru) * 2003-11-20 2009-02-27 Янссен Фармацевтика Н. В. 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
JP4864718B2 (ja) * 2003-11-20 2012-02-01 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤としての６−アルケニルおよび６−フェニルアルキル置換２−キノリノンおよび２−キノキサリノン
EA009875B1 (ru) * 2003-11-20 2008-04-28 Янссен Фармацевтика Н.В. 6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
AU2004295059B2 (en) * 2003-12-05 2010-12-16 Janssen Pharmaceutica N.V. 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
EA010592B1 (ru) * 2003-12-10 2008-10-30 Янссен Фармацевтика Н.В. 6-замещённые циклогексилалкил 2-замещённые хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(adp-рибоза)полимеразы
SG154433A1 (en) 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Phthalazine derivatives as parp inhibitors
MXPA06014933A (es) 2004-06-30 2007-02-28 Janssen Pharmaceutica Nv Derivados de 2-alquil quinazolinona sustituidos como inhibidores de poli(adp-ribosa) polimerasa-1.
MXPA06014541A (es) 2004-06-30 2007-03-23 Janssen Pharmaceutica Nv Derivados de quinazolindiona como inhibidores de la poli(adp-ribosa) polimerasa.
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
JP4643948B2 (ja) * 2004-08-23 2011-03-02 大日本住友製薬株式会社 キナゾリノン化合物の安定化方法
WO2007092854A2 (en) 2006-02-06 2007-08-16 Janssen Pharmaceutica N.V. 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
US7932261B2 (en) 2006-02-06 2011-04-26 Janssen Pharmaceutica Nv Macrocycle derivatives useful as inhibitors of β-secretase (BACE)
KR101307497B1 (ko) * 2006-04-19 2013-09-11 주식회사 동진쎄미켐 디이미다졸계 화합물 및 이를 이용한 유기발광소자
US7429589B2 (en) * 2006-04-27 2008-09-30 Hoffmann-La Roche Inc. Mono-nitration of aromatic compounds via nitrate salts
US20080076800A1 (en) * 2006-08-24 2008-03-27 Huang Kenneth H Benzene, Pyridine, and Pyridazine Derivatives
US8299256B2 (en) 2007-03-08 2012-10-30 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
US8404713B2 (en) 2007-10-26 2013-03-26 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP inhibitors
US8076358B2 (en) 2008-01-28 2011-12-13 Janssen Pharmaceutica Nv 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
CA2716726C (en) 2008-03-27 2017-01-24 Janssen Pharmaceutica Nv Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
JP5464609B2 (ja) 2008-03-27 2014-04-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ チューブリン重合阻害剤としてのキナゾリノン誘導体
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
EP2760854B1 (en) * 2011-09-30 2017-08-30 Asana BioSciences, LLC Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
CA2888485C (en) 2012-10-16 2021-01-26 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror.gamma.t
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
ES2619610T3 (es) 2012-10-16 2017-06-26 Janssen Pharmaceutica Nv Moduladores de ROR-gamma-t de quinolinilo enlazado con heteroarilo
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
ES2742843T3 (es) 2013-10-15 2020-02-17 Janssen Pharmaceutica Nv Moduladores de quinolinilo de ROR(gamma)t
BR112016008215A2 (pt) 2013-10-15 2017-09-26 Janssen Pharmaceutica Nv moduladores de quinolinila ligados por alquila de roryt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101115A (en) * 1980-10-23 1983-01-12 Pfizer Ltd Thromboxane synthetase inhibitors
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
FR2629456B1 (fr) * 1988-03-31 1991-07-05 Esteve Labor Dr Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments

Also Published As

Publication number Publication date
HK118196A (en) 1996-07-12
CN1042912A (zh) 1990-06-13
JPH02223579A (ja) 1990-09-05
CN1106005A (zh) 1995-08-02
HU205106B (en) 1992-03-30
CN1036002C (zh) 1997-10-01
FI101964B (fi) 1998-09-30
NZ231441A (en) 1991-05-28
NO894734L (no) 1990-05-30
CA2002864C (en) 1999-11-16
CY1920A (en) 1997-03-07
NO174509C (pt) 1994-05-18
RU1780536C (ru) 1992-12-07
PT92448A (pt) 1990-05-31
HUT52498A (en) 1990-07-28
DE68923430T2 (de) 1996-02-15
IE893782L (en) 1990-05-29
CN1036003C (zh) 1997-10-01
DK172748B1 (da) 1999-06-28
DK599489A (da) 1990-05-30
ZW15889A1 (en) 1991-07-17
FI101964B1 (fi) 1998-09-30
AU4564689A (en) 1990-06-07
CA2002864A1 (en) 1990-05-29
CN1033752C (zh) 1997-01-08
IE67803B1 (en) 1996-05-01
DK599489D0 (da) 1989-11-28
MY105871A (en) 1995-02-28
EP0371564A2 (en) 1990-06-06
DE68923430D1 (de) 1995-08-17
JP2916181B2 (ja) 1999-07-05
FI895687A0 (fi) 1989-11-28
IL92486A (en) 1993-07-08
AU620946B2 (en) 1992-02-27
ES2088889T3 (es) 1996-10-01
HU211686A9 (en) 1995-12-28
HU896220D0 (en) 1990-02-28
NO894734D0 (no) 1989-11-28
CN1106004A (zh) 1995-08-02
GR3017351T3 (en) 1995-12-31
ATE124941T1 (de) 1995-07-15
EP0371564A3 (en) 1991-05-29
EP0371564B1 (en) 1995-07-12
PT92448B (pt) 1995-07-18
IL92486A0 (en) 1990-08-31

Similar Documents

Publication Publication Date Title
NO174509B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1H-azol- 1-ylmetyl)substituerte kinolin-, kinazolin- eller kinoksazolinderivater
EP0293978B1 (en) (1h-azol-1-ylmethyl)substituted benzotriazole derivatives
EP2528901B9 (en) Pyrazole compounds as crth2 antagonists
US20040043983A1 (en) Naphthalene derivatives as matrix metalloproteinase inhibitors
US5151421A (en) (1h-azol-1-ylmethyl) substituted quinoxaline derivatives
NO312102B1 (no) N-[4-(Heteroarylmetyl)fenyl]-Heteroarylaminer
JPH10508317A (ja) 抗真菌活性を有する新規ピリミドン誘導体
CA2577420C (en) Lonidamine analogues and their use in male contraception and cancer treatment
US20040043986A1 (en) 5,6-Fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
US6869958B2 (en) Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
EP0641785B1 (en) Triazolylated tertiary amine compound or salt thereof
JP2000072675A (ja) 医薬組成物
US4943574A (en) (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
WO2004014378A1 (en) 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors
KR0149162B1 (ko) (1h-아졸-1-일메틸) 치환된 퀴놀린, 퀴나졸린 또는 퀴녹살린 유도체
JP2500849B2 (ja) トリアゾリル置換３級アミノ化合物又はその塩
US5039677A (en) 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles